Doxorubicin pathways: pharmacodynamics and adverse effects

被引:1295
作者
Thorn, Caroline F. [1 ]
Oshiro, Connie [1 ]
Marsh, Sharon [5 ]
Hernandez-Boussard, Tina [2 ]
McLeod, Howard [4 ]
Klein, Teri E. [1 ]
Altman, Russ B. [1 ,3 ]
机构
[1] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA
[3] Stanford Univ, Med Ctr, Dept Bioengn, Stanford, CA 94305 USA
[4] Univ N Carolina, Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC USA
[5] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
ABCC1; ABCC2; anthracyclines; cardiotoxicity; CAT; CBR3; CYBA; doxorubicin; drug resistance; NCF4; pharmacogenomics; PharmGKBpathways; RAC2; CONGESTIVE-HEART-FAILURE; BREAST-CANCER PATIENTS; MULTIDRUG-RESISTANCE; LUNG-CANCER; IN-VITRO; ANTHRACYCLINE CARDIOTOXICITY; GENETIC POLYMORPHISMS; TOPOISOMERASE-II; NITRIC-OXIDE; PHARMACOGENETICS;
D O I
10.1097/FPC.0b013e32833ffb56
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:440 / 446
页数:7
相关论文
共 61 条
[1]   ADRIAMYCIN, 14-HYDROXYDAUNOMYCIN, A NEW ANTITUMOR ANTIBIOTIC FROM S-PEUCETIUS VAR CAESIUS [J].
ARCAMONE, F ;
CASSINEL.G ;
FANTINI, G ;
GREIN, A ;
OREZZI, P ;
POL, C ;
SPALLA, C .
BIOTECHNOLOGY AND BIOENGINEERING, 1969, 11 (06) :1101-&
[2]   Naturally Occurring Variants of Human CBR3 Alter Anthracycline In Vitro Metabolism [J].
Bains, Onkar S. ;
Karkling, Morgan J. ;
Lubieniecka, Joanna M. ;
Grigliatti, Thomas A. ;
Reid, Ronald E. ;
Riggs, K. Wayne .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (03) :755-763
[3]   Two Nonsynonymous Single Nucleotide Polymorphisms of Human Carbonyl Reductase 1 Demonstrate Reduced in Vitro Metabolism of Daunorubicin and Doxorubicin [J].
Bains, Onkar S. ;
Karkling, Morgan J. ;
Grigliatti, Thomas A. ;
Reid, Ronald E. ;
Riggs, K. Wayne .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (05) :1107-1114
[4]   Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:Quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer [J].
Blanco, Javier G. ;
Leisenring, Wendy M. ;
Gonzalez-Covarrubias, Vanessa M. ;
Kawashima, Toana I. ;
Davies, Stella M. ;
Relling, Mary V. ;
Robison, Leslie L. ;
Sklar, Charles A. ;
Stovall, Marilyn ;
Bhatia, Smita .
CANCER, 2008, 112 (12) :2789-2795
[5]   Topoisomerase levels determine chemotherapy response in vitro and in vivo [J].
Burgess, Darren J. ;
Doles, Jason ;
Zender, Lars ;
Xue, Wen ;
Ma, Beicong ;
McCombie, W. Richard ;
Hannon, Gregory J. ;
Lowe, Scott W. ;
Hemann, Michael T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (26) :9053-9058
[6]   Doxorubicin: The Good, the Bad and the Ugly Effect [J].
Carvalho, Cristina ;
Santos, Renato X. ;
Cardoso, Susana ;
Correia, Sonia ;
Oliveira, Paulo J. ;
Santos, Maria S. ;
Moreira, Paula I. .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (25) :3267-3285
[7]   Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial [J].
Choi, Ji-Yeob ;
Barlow, William E. ;
Albain, Kathy S. ;
Hong, Chi-Chen ;
Blanco, Javier G. ;
Livingston, Robert B. ;
Davis, Warren ;
Rae, James M. ;
Yeh, I-Tien ;
Hutchins, Laura F. ;
Ravdin, Peter M. ;
Martino, Silvana ;
Lyss, Alan P. ;
Osborne, C. Kent ;
Abeloff, Martin D. ;
Hayes, Daniel F. ;
Ambrosone, Christine B. .
CLINICAL CANCER RESEARCH, 2009, 15 (16) :5258-5266
[8]  
Clementi ME, 2003, ANTICANCER RES, V23, P2445
[9]   OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
COLE, SPC ;
BHARDWAJ, G ;
GERLACH, JH ;
MACKIE, JE ;
GRANT, CE ;
ALMQUIST, KC ;
STEWART, AJ ;
KURZ, EU ;
DUNCAN, AMV ;
DEELEY, RG .
SCIENCE, 1992, 258 (5088) :1650-1654
[10]  
COLOMBO T, 1994, J PHARMACOL EXP THER, V269, P22